First Washington Corp Neuronetics, Inc. Transaction History
First Washington Corp
- $255 Million
- Q1 2024
A detailed history of First Washington Corp transactions in Neuronetics, Inc. stock. As of the latest transaction made, First Washington Corp holds 675,085 shares of STIM stock, worth $1.22 Million. This represents 1.26% of its overall portfolio holdings.
Number of Shares
675,085
Previous 470,683
43.43%
Holding current value
$1.22 Million
Previous $1.36 Million
135.56%
% of portfolio
1.26%
Previous 0.53%
Shares
9 transactions
Others Institutions Holding STIM
# of Institutions
68Shares Held
18.4MCall Options Held
200Put Options Held
3.6K-
Archon Capital Management LLC Seattle, WA2.54MShares$4.57 Million4.16% of portfolio
-
Cannell Capital LLC Alta, WY2.46MShares$4.43 Million2.78% of portfolio
-
Divisadero Street Capital Management, LP Miami, FL1.54MShares$2.77 Million1.85% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.3MShares$2.34 Million0.0% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY1.18MShares$2.12 Million0.04% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $48.6M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...